Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) Gross Profit: 2016-2024

Historic Gross Profit for Organogenesis Holdings (ORGO) over the last 9 years, with Dec 2024 value amounting to $366.3 million.

  • Organogenesis Holdings' Gross Profit rose 10.49% to $97.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $308.3 million, marking a year-over-year decrease of 10.01%. This contributed to the annual value of $366.3 million for FY2024, which is 12.14% up from last year.
  • According to the latest figures from FY2024, Organogenesis Holdings' Gross Profit is $366.3 million, which was up 12.14% from $326.7 million recorded in FY2023.
  • Organogenesis Holdings' 5-year Gross Profit high stood at $366.3 million for FY2024, and its period low was $251.0 million during FY2020.
  • In the last 3 years, Organogenesis Holdings' Gross Profit had a median value of $345.9 million in 2022 and averaged $346.3 million.
  • Per our database at Business Quant, Organogenesis Holdings' Gross Profit skyrocketed by 40.71% in 2021 and then decreased by 5.56% in 2023.
  • Organogenesis Holdings' Gross Profit (Yearly) stood at $251.0 million in 2020, then surged by 40.71% to $353.2 million in 2021, then fell by 2.06% to $345.9 million in 2022, then decreased by 5.56% to $326.7 million in 2023, then grew by 12.14% to $366.3 million in 2024.